Last Week's Best Healthcare ETF
It was another rough week for the healthcare sector, but this healthcare ETF performed the best.
Grading Gilead Sciences' Performance in 2015
The highs and lows (but mostly highs) from Gilead Sciences’ earnings call.
1 Company Gilead Sciences Should Consider Buying Right Now
Given that it's flush with cash but shaky on growth, an acquisition could be in Gilead Sciences future. This company stands out as the most obvious target.
Gilead Sciences 2016 Guidance: Sandbagging Wall Street Again?
The company's track record of beating forecasts could continue again this year.
5 Stocks We're Buying Again
Here's what five Fools are buying while the market is down.